BREVIBLOC PREMIXED INJECTION
Google image searchProduct monograph
Active ingredient
esmolol hydrochloride, 10 MG/ML
DIN: 02309238
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: BAXTER CORPORATION
Date: 12-SEP-2008
ATC:
- C07 — BETA BLOCKING AGENTS (ATC, ATC/DDD, )
- C07A — BETA BLOCKING AGENTS (ATC, ATC/DDD)
- C07AB — Beta blocking agents, selective (ATC, ATC/DDD)
- C07AB09 — ESMOLOL (ATC/DDD)
Reference brand drug: Brevibloc
Pharmaceutical standard: MFR
